DEA changes marijuana policy under Chad Chronister by December 31, 2025?
Yes • 50%
No • 50%
Official DEA announcements or policy changes reported by major news outlets
Trump's DEA Nominee Chad Chronister Criticized for Arresting Pastor During Covid Lockdown
Dec 1, 2024, 04:33 PM
President Donald Trump has nominated Chad Chronister, the Sheriff of Hillsborough County, Florida, to lead the Drug Enforcement Administration (DEA). Chronister's nomination has sparked controversy due to his past actions during the Covid-19 lockdown, where he arrested Pastor Rodney Howard-Browne for holding church services in violation of public health orders. Critics, including figures like Rep. Thomas Massie and Mike Cernovich, argue that this incident disqualifies him from the position, citing concerns over his enforcement of draconian laws without discernment. However, Chronister has also been noted for his support of local marijuana decriminalization policies in Tampa, which could influence his approach to drug policy at the DEA. Despite the backlash, Pastor Howard-Browne has publicly forgiven Chronister, and they remain friends.
View original story
No • 50%
Yes • 50%
Other • 25%
No Significant Change • 25%
Policy Reform Initiatives • 25%
Increased Enforcement Actions • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Other • 25%
Opioid crisis management • 25%
Community policing enhancement • 25%
Drug trafficking crackdown • 25%
Increased federal-state cooperation • 25%
Focus on opioid crisis • 25%
Other • 25%
Drug enforcement reform • 25%
Fentanyl Trafficking • 25%
Other • 25%
Border Security • 25%
Marijuana Decriminalization • 25%
No decision by deadline • 25%
Confirmed • 25%
Withdrawn • 25%
Rejected • 25%
Nomination expired • 25%
Rejected • 25%
Withdrawn before vote • 25%
Confirmed • 25%
More Favorable • 25%
Mixed Results • 25%
No Change • 25%
Less Favorable • 25%
Yes • 50%
No • 50%
Nomination stalled • 25%
Confirmed • 25%
Rejected • 25%
Withdrawn by President • 25%
Other reasons • 25%
Controversy over Pastor's arrest • 25%
Opposition to drug policy stance • 25%
Political reasons unrelated to controversy • 25%